This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Andrej Francky: Innovator in Mammalian Expression Vectors
Introduction
Andrej Francky is a notable inventor based in Menges, Slovenia. He has made significant contributions to the field of biotechnology, particularly in the development of mammalian expression vectors. His work has implications for various applications in genetic engineering and therapeutic development.
Latest Patents
Andrej Francky holds a patent for a mammalian expression vector. The invention describes new mammalian expression vectors that comprise a novel combination of regulatory elements and one or more selection marker genes. This vector allows for the incorporation of at least one, preferably two or more genes of interest, enabling their subsequent expression. Additionally, it facilitates the selection of transfected cells using agents such as G418 and/or MTX. The pDGPΔGOI vector, as an example of this invention, exhibits a 9555 bp sequence, with one strand represented by SEQ ID NO:2.
Career Highlights
Andrej Francky is currently employed at Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. His work at Lek Pharmaceuticals has allowed him to focus on innovative solutions in biotechnology and contribute to advancements in the field.
Collaborations
Andrej collaborates with Dominik Gaser, who is also involved in the research and development of biotechnological innovations. Their partnership enhances the potential for groundbreaking discoveries in their area of expertise.
Conclusion
Andrej Francky is a distinguished inventor whose work on mammalian expression vectors has the potential to impact various biotechnological applications. His contributions to the field exemplify the importance of innovation in advancing scientific research and development.